Texas Yale Capital Corp. Ligand Pharmaceuticals Inc Transaction History

Texas Yale Capital Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 24, 2019	SELL	$107.38 - $129.34 $358,004 - $431,219	-3,334 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$105.93 - $142.47 $185,483 - $249,464	1,751 Added 110.61%	3,334 $420,000
Q4 2018 Feb 11, 2019	BUY	$128.36 - $272.13 $203,193 - $430,781	1,583 New	1,583 $215,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

Stay updated on Texas Yale Capital Corp. with notifications on news.